On August 11, Medipost announced that it will collaborate with Woongjin Preedlife to offer a new cell storage conversion service to existing Woongjin Preedlife members.


Medipost and Woongjin Preedlife Offer 'Cell Storage Conversion Service' for Funeral Service Members View original image

This partnership was established to expand customer choices from funeral services to the healthcare sector, in response to increasing consumer interest in health management. Woongjin Preedlife members can use Medipost's cell storage services by utilizing the conversion service options available to the products they have purchased.


The new conversion service consists of two products—'Adipose-derived Stem Cell Storage' and 'Immune Cell Storage'—allowing customers to choose based on their needs and purposes. Woongjin Preedlife will explain the service details and usage instructions to its customers, verify their intention to use the service, and then refer them to Medipost. Medipost will then provide further guidance on the storage service procedures and execute the contract directly with the customer.


Adipose tissue and peripheral blood collection are safely conducted by medical professionals at partner medical institutions, following established procedures and medical judgment. The collected adipose tissue and peripheral blood are transported according to strict logistics standards. Medipost is responsible for cell separation, testing, processing, and long-term storage work.



A Medipost representative stated, "We expect to generate synergy by combining the customer service foundation of Woongjin Preedlife with Medipost's expertise and operational capabilities in cell-related technology. Moving forward, we will continue to provide differentiated healthcare services so that customers can prepare for a healthier future."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing